Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Ciprofloxacin
- Therapeutic area
- Anti-infectives
- Drug class
- Fluoroquinolone antibacterials
- ATC
- J01MA
- Strength
- 250 mg
- Dosage form
- Tablet
- Pack
- 10's
- Registration no.
- 013811
- Price record verified
- 2026-08-24
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
Efroze Chemical Industries Pvt. Ltd.
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 332.37 to 348.79 (+4.9%) between 11 Aug 2025 and 18 Aug 2026 · 2 official price records · pack 10's
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Roxin 250 mg, 10's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/roxin-250-mg-013811-10s-efroze-chemical-industries-pvt-ltd/ (accessed 25 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 348.79 | 2026-08-18 | 2026-08-24 | DRAP PharmaPrice Index | Current |
| PKR 332.37 | 2025-08-11 | 2026-08-08 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 013811Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.
